0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pain Management Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-8R9452
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pain Management Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Pain Management Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-8R9452
Report
August 2025
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pain Management Drugs- Market Size

The global market for Pain Management Drugs was estimated to be worth US$ 37760 million in 2024 and is forecast to a readjusted size of US$ 47240 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.

Pain Management Drugs- Market

Pain Management Drugs- Market

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.
This report aims to provide a comprehensive presentation of the global market for Pain Management Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pain Management Drugs by region & country, by Type, and by Application.
The Pain Management Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Management Drugs.
Market Segmentation

Scope of Pain Management Drugs- Market Report

Report Metric Details
Report Name Pain Management Drugs- Market
Forecasted market size in 2031 US$ 47240 million
CAGR 3.3%
Forecasted years 2025 - 2031
Segment by Type
  • Generic Opioids
  • Branded Opioids
  • NSAIDs
  • Others
Segment by Application
  • Hospitals
  • Drugstores
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo, Merck, Yunnan Baiyao, Teikoku Seiyaku, Teva, J&J, Assertio Therapeutics, Allergan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Pain Management Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Pain Management Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Pain Management Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Pain Management Drugs- Market size in 2031?

Ans: The Pain Management Drugs- Market size in 2031 will be US$ 47240 million.

What is the GSK share in Pain Management Drugs- Market?

Ans: The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019.

Who are the main players in the Pain Management Drugs- Market report?

Ans: The main players in the Pain Management Drugs- Market are GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo, Merck, Yunnan Baiyao, Teikoku Seiyaku, Teva, J&J, Assertio Therapeutics, Allergan

What are the Application segmentation covered in the Pain Management Drugs- Market report?

Ans: The Applications covered in the Pain Management Drugs- Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Pain Management Drugs- Market report?

Ans: The Types covered in the Pain Management Drugs- Market report are Generic Opioids, Branded Opioids, NSAIDs, Others

1 Market Overview
1.1 Pain Management Drugs Product Introduction
1.2 Global Pain Management Drugs Market Size Forecast (2020-2031)
1.3 Pain Management Drugs Market Trends & Drivers
1.3.1 Pain Management Drugs Industry Trends
1.3.2 Pain Management Drugs Market Drivers & Opportunity
1.3.3 Pain Management Drugs Market Challenges
1.3.4 Pain Management Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pain Management Drugs Players Revenue Ranking (2024)
2.2 Global Pain Management Drugs Revenue by Company (2020-2025)
2.3 Key Companies Pain Management Drugs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pain Management Drugs Product Offered
2.5 Key Companies Time to Begin Mass Production of Pain Management Drugs
2.6 Pain Management Drugs Market Competitive Analysis
2.6.1 Pain Management Drugs Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Pain Management Drugs Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Management Drugs as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Generic Opioids
3.1.2 Branded Opioids
3.1.3 NSAIDs
3.1.4 Others
3.2 Global Pain Management Drugs Sales Value by Type
3.2.1 Global Pain Management Drugs Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Pain Management Drugs Sales Value, by Type (2020-2031)
3.2.3 Global Pain Management Drugs Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Drugstores
4.1.3 Others
4.2 Global Pain Management Drugs Sales Value by Application
4.2.1 Global Pain Management Drugs Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Pain Management Drugs Sales Value, by Application (2020-2031)
4.2.3 Global Pain Management Drugs Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Pain Management Drugs Sales Value by Region
5.1.1 Global Pain Management Drugs Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Pain Management Drugs Sales Value by Region (2020-2025)
5.1.3 Global Pain Management Drugs Sales Value by Region (2026-2031)
5.1.4 Global Pain Management Drugs Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Pain Management Drugs Sales Value, 2020-2031
5.2.2 North America Pain Management Drugs Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Pain Management Drugs Sales Value, 2020-2031
5.3.2 Europe Pain Management Drugs Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Pain Management Drugs Sales Value, 2020-2031
5.4.2 Asia Pacific Pain Management Drugs Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Pain Management Drugs Sales Value, 2020-2031
5.5.2 South America Pain Management Drugs Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pain Management Drugs Sales Value, 2020-2031
5.6.2 Middle East & Africa Pain Management Drugs Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pain Management Drugs Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Pain Management Drugs Sales Value, 2020-2031
6.3 United States
6.3.1 United States Pain Management Drugs Sales Value, 2020-2031
6.3.2 United States Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Pain Management Drugs Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Pain Management Drugs Sales Value, 2020-2031
6.4.2 Europe Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Pain Management Drugs Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Pain Management Drugs Sales Value, 2020-2031
6.5.2 China Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
6.5.3 China Pain Management Drugs Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Pain Management Drugs Sales Value, 2020-2031
6.6.2 Japan Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Pain Management Drugs Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Pain Management Drugs Sales Value, 2020-2031
6.7.2 South Korea Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Pain Management Drugs Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Pain Management Drugs Sales Value, 2020-2031
6.8.2 Southeast Asia Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Pain Management Drugs Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Pain Management Drugs Sales Value, 2020-2031
6.9.2 India Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
6.9.3 India Pain Management Drugs Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 GSK
7.1.1 GSK Profile
7.1.2 GSK Main Business
7.1.3 GSK Pain Management Drugs Products, Services and Solutions
7.1.4 GSK Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.1.5 GSK Recent Developments
7.2 Pfizer
7.2.1 Pfizer Profile
7.2.2 Pfizer Main Business
7.2.3 Pfizer Pain Management Drugs Products, Services and Solutions
7.2.4 Pfizer Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.2.5 Pfizer Recent Developments
7.3 Grunenthal
7.3.1 Grunenthal Profile
7.3.2 Grunenthal Main Business
7.3.3 Grunenthal Pain Management Drugs Products, Services and Solutions
7.3.4 Grunenthal Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.3.5 Grunenthal Recent Developments
7.4 Sanofi
7.4.1 Sanofi Profile
7.4.2 Sanofi Main Business
7.4.3 Sanofi Pain Management Drugs Products, Services and Solutions
7.4.4 Sanofi Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.4.5 Sanofi Recent Developments
7.5 Bayer
7.5.1 Bayer Profile
7.5.2 Bayer Main Business
7.5.3 Bayer Pain Management Drugs Products, Services and Solutions
7.5.4 Bayer Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.5.5 Bayer Recent Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Profile
7.6.2 AstraZeneca Main Business
7.6.3 AstraZeneca Pain Management Drugs Products, Services and Solutions
7.6.4 AstraZeneca Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.6.5 AstraZeneca Recent Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Profile
7.7.2 Eli Lilly Main Business
7.7.3 Eli Lilly Pain Management Drugs Products, Services and Solutions
7.7.4 Eli Lilly Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.7.5 Eli Lilly Recent Developments
7.8 Endo
7.8.1 Endo Profile
7.8.2 Endo Main Business
7.8.3 Endo Pain Management Drugs Products, Services and Solutions
7.8.4 Endo Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.8.5 Endo Recent Developments
7.9 Merck
7.9.1 Merck Profile
7.9.2 Merck Main Business
7.9.3 Merck Pain Management Drugs Products, Services and Solutions
7.9.4 Merck Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.9.5 Merck Recent Developments
7.10 Yunnan Baiyao
7.10.1 Yunnan Baiyao Profile
7.10.2 Yunnan Baiyao Main Business
7.10.3 Yunnan Baiyao Pain Management Drugs Products, Services and Solutions
7.10.4 Yunnan Baiyao Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.10.5 Yunnan Baiyao Recent Developments
7.11 Teikoku Seiyaku
7.11.1 Teikoku Seiyaku Profile
7.11.2 Teikoku Seiyaku Main Business
7.11.3 Teikoku Seiyaku Pain Management Drugs Products, Services and Solutions
7.11.4 Teikoku Seiyaku Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.11.5 Teikoku Seiyaku Recent Developments
7.12 Teva
7.12.1 Teva Profile
7.12.2 Teva Main Business
7.12.3 Teva Pain Management Drugs Products, Services and Solutions
7.12.4 Teva Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.12.5 Teva Recent Developments
7.13 J&J
7.13.1 J&J Profile
7.13.2 J&J Main Business
7.13.3 J&J Pain Management Drugs Products, Services and Solutions
7.13.4 J&J Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.13.5 J&J Recent Developments
7.14 Assertio Therapeutics
7.14.1 Assertio Therapeutics Profile
7.14.2 Assertio Therapeutics Main Business
7.14.3 Assertio Therapeutics Pain Management Drugs Products, Services and Solutions
7.14.4 Assertio Therapeutics Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.14.5 Assertio Therapeutics Recent Developments
7.15 Allergan
7.15.1 Allergan Profile
7.15.2 Allergan Main Business
7.15.3 Allergan Pain Management Drugs Products, Services and Solutions
7.15.4 Allergan Pain Management Drugs Revenue (US$ Million) & (2020-2025)
7.15.5 Allergan Recent Developments
8 Industry Chain Analysis
8.1 Pain Management Drugs Industrial Chain
8.2 Pain Management Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pain Management Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Pain Management Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Pain Management Drugs Market Trends
 Table 2. Pain Management Drugs Market Drivers & Opportunity
 Table 3. Pain Management Drugs Market Challenges
 Table 4. Pain Management Drugs Market Restraints
 Table 5. Global Pain Management Drugs Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Pain Management Drugs Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Pain Management Drugs Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Pain Management Drugs Product Type
 Table 9. Key Companies Time to Begin Mass Production of Pain Management Drugs
 Table 10. Global Pain Management Drugs Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Management Drugs as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Pain Management Drugs Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Pain Management Drugs Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Pain Management Drugs Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Pain Management Drugs Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Pain Management Drugs Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Pain Management Drugs Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Pain Management Drugs Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Pain Management Drugs Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Pain Management Drugs Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Pain Management Drugs Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Pain Management Drugs Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Pain Management Drugs Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Pain Management Drugs Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Pain Management Drugs Sales Value by Region (2020-2025) & (%)
 Table 27. Global Pain Management Drugs Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Pain Management Drugs Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Pain Management Drugs Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Pain Management Drugs Sales Value, (2026-2031) & (US$ Million)
 Table 31. GSK Basic Information List
 Table 32. GSK Description and Business Overview
 Table 33. GSK Pain Management Drugs Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Pain Management Drugs Business of GSK (2020-2025)
 Table 35. GSK Recent Developments
 Table 36. Pfizer Basic Information List
 Table 37. Pfizer Description and Business Overview
 Table 38. Pfizer Pain Management Drugs Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Pain Management Drugs Business of Pfizer (2020-2025)
 Table 40. Pfizer Recent Developments
 Table 41. Grunenthal Basic Information List
 Table 42. Grunenthal Description and Business Overview
 Table 43. Grunenthal Pain Management Drugs Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Pain Management Drugs Business of Grunenthal (2020-2025)
 Table 45. Grunenthal Recent Developments
 Table 46. Sanofi Basic Information List
 Table 47. Sanofi Description and Business Overview
 Table 48. Sanofi Pain Management Drugs Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Pain Management Drugs Business of Sanofi (2020-2025)
 Table 50. Sanofi Recent Developments
 Table 51. Bayer Basic Information List
 Table 52. Bayer Description and Business Overview
 Table 53. Bayer Pain Management Drugs Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Pain Management Drugs Business of Bayer (2020-2025)
 Table 55. Bayer Recent Developments
 Table 56. AstraZeneca Basic Information List
 Table 57. AstraZeneca Description and Business Overview
 Table 58. AstraZeneca Pain Management Drugs Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Pain Management Drugs Business of AstraZeneca (2020-2025)
 Table 60. AstraZeneca Recent Developments
 Table 61. Eli Lilly Basic Information List
 Table 62. Eli Lilly Description and Business Overview
 Table 63. Eli Lilly Pain Management Drugs Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Pain Management Drugs Business of Eli Lilly (2020-2025)
 Table 65. Eli Lilly Recent Developments
 Table 66. Endo Basic Information List
 Table 67. Endo Description and Business Overview
 Table 68. Endo Pain Management Drugs Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Pain Management Drugs Business of Endo (2020-2025)
 Table 70. Endo Recent Developments
 Table 71. Merck Basic Information List
 Table 72. Merck Description and Business Overview
 Table 73. Merck Pain Management Drugs Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Pain Management Drugs Business of Merck (2020-2025)
 Table 75. Merck Recent Developments
 Table 76. Yunnan Baiyao Basic Information List
 Table 77. Yunnan Baiyao Description and Business Overview
 Table 78. Yunnan Baiyao Pain Management Drugs Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Pain Management Drugs Business of Yunnan Baiyao (2020-2025)
 Table 80. Yunnan Baiyao Recent Developments
 Table 81. Teikoku Seiyaku Basic Information List
 Table 82. Teikoku Seiyaku Description and Business Overview
 Table 83. Teikoku Seiyaku Pain Management Drugs Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Pain Management Drugs Business of Teikoku Seiyaku (2020-2025)
 Table 85. Teikoku Seiyaku Recent Developments
 Table 86. Teva Basic Information List
 Table 87. Teva Description and Business Overview
 Table 88. Teva Pain Management Drugs Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Pain Management Drugs Business of Teva (2020-2025)
 Table 90. Teva Recent Developments
 Table 91. J&J Basic Information List
 Table 92. J&J Description and Business Overview
 Table 93. J&J Pain Management Drugs Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Pain Management Drugs Business of J&J (2020-2025)
 Table 95. J&J Recent Developments
 Table 96. Assertio Therapeutics Basic Information List
 Table 97. Assertio Therapeutics Description and Business Overview
 Table 98. Assertio Therapeutics Pain Management Drugs Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Pain Management Drugs Business of Assertio Therapeutics (2020-2025)
 Table 100. Assertio Therapeutics Recent Developments
 Table 101. Allergan Basic Information List
 Table 102. Allergan Description and Business Overview
 Table 103. Allergan Pain Management Drugs Products, Services and Solutions
 Table 104. Revenue (US$ Million) in Pain Management Drugs Business of Allergan (2020-2025)
 Table 105. Allergan Recent Developments
 Table 106. Key Raw Materials Lists
 Table 107. Raw Materials Key Suppliers Lists
 Table 108. Pain Management Drugs Downstream Customers
 Table 109. Pain Management Drugs Distributors List
 Table 110. Research Programs/Design for This Report
 Table 111. Key Data Information from Secondary Sources
 Table 112. Key Data Information from Primary Sources
 Table 113. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Pain Management Drugs Product Picture
 Figure 2. Global Pain Management Drugs Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Pain Management Drugs Sales Value (2020-2031) & (US$ Million)
 Figure 4. Pain Management Drugs Report Years Considered
 Figure 5. Global Pain Management Drugs Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pain Management Drugs Revenue in 2024
 Figure 7. Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Generic Opioids Picture
 Figure 9. Branded Opioids Picture
 Figure 10. NSAIDs Picture
 Figure 11. Others Picture
 Figure 12. Global Pain Management Drugs Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 13. Global Pain Management Drugs Sales Value Market Share by Type, 2024 & 2031
 Figure 14. Product Picture of Hospitals
 Figure 15. Product Picture of Drugstores
 Figure 16. Product Picture of Others
 Figure 17. Global Pain Management Drugs Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 18. Global Pain Management Drugs Sales Value Market Share by Application, 2024 & 2031
 Figure 19. North America Pain Management Drugs Sales Value (2020-2031) & (US$ Million)
 Figure 20. North America Pain Management Drugs Sales Value by Country (%), 2024 VS 2031
 Figure 21. Europe Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 22. Europe Pain Management Drugs Sales Value by Country (%), 2024 VS 2031
 Figure 23. Asia Pacific Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 24. Asia Pacific Pain Management Drugs Sales Value by Region (%), 2024 VS 2031
 Figure 25. South America Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 26. South America Pain Management Drugs Sales Value by Country (%), 2024 VS 2031
 Figure 27. Middle East & Africa Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 28. Middle East & Africa Pain Management Drugs Sales Value by Country (%), 2024 VS 2031
 Figure 29. Key Countries/Regions Pain Management Drugs Sales Value (%), (2020-2031)
 Figure 30. United States Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 31. United States Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
 Figure 32. United States Pain Management Drugs Sales Value by Application (%), 2024 VS 2031
 Figure 33. Europe Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 34. Europe Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
 Figure 35. Europe Pain Management Drugs Sales Value by Application (%), 2024 VS 2031
 Figure 36. China Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 37. China Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
 Figure 38. China Pain Management Drugs Sales Value by Application (%), 2024 VS 2031
 Figure 39. Japan Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 40. Japan Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
 Figure 41. Japan Pain Management Drugs Sales Value by Application (%), 2024 VS 2031
 Figure 42. South Korea Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 43. South Korea Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
 Figure 44. South Korea Pain Management Drugs Sales Value by Application (%), 2024 VS 2031
 Figure 45. Southeast Asia Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 46. Southeast Asia Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
 Figure 47. Southeast Asia Pain Management Drugs Sales Value by Application (%), 2024 VS 2031
 Figure 48. India Pain Management Drugs Sales Value, (2020-2031) & (US$ Million)
 Figure 49. India Pain Management Drugs Sales Value by Type (%), 2024 VS 2031
 Figure 50. India Pain Management Drugs Sales Value by Application (%), 2024 VS 2031
 Figure 51. Pain Management Drugs Industrial Chain
 Figure 52. Pain Management Drugs Manufacturing Cost Structure
 Figure 53. Channels of Distribution (Direct Sales, and Distribution)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India